Product Program year 2020 Source: CMS Open Payments

(820) Cholbam

Drug (820) Cholbam

NDC 45043-001-02

Open in the dashboard

General payments

$60

13 payments

Research payments

$0

0 payments

Through program year 2020, $60 in general payments and $0 in research payments were reported against (820) Cholbam ((820) Cholbam).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

1 row
Year Kind Amount Payments
2020 General $60 13

Breakdown

Who paid General payments · program year 2020
  1. Retrophin, Inc. $60 13 payments
Top recipients General payments · program year 2020
  1. Janine Collinge Pediatric Ophthalmology and Strabismus Specialist · Rocky Hill, CT $20 33% · 1 payment
  2. Nicole Zeky Pediatric Gastroenterology · Cincinnati, OH $16 27% · 1 payment
  3. Noah Hoffman Pediatric Gastroenterology · Portland, ME $14 23% · 2 payments
  4. Kevin Sztam Pediatric Gastroenterology · Portland, ME $4 6% · 2 payments
  5. Mary Boruta Pediatric Gastroenterology · Charlotte, NC $2 3% · 2 payments

The top 5 of 8 recipients; each share is of general payments naming this product in 2020.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2020
  1. Pediatric Gastroenterology Pediatrics $38 63% · 5 practitioners
  2. Pediatric Ophthalmology and Strabismus Specialist Ophthalmology $20 33% · 1 practitioner
  3. Neurology Psychiatry & Neurology $2 3% · 1 practitioner
  4. Neonatal-Perinatal Medicine Pediatrics $1 1% · 1 practitioner

Each share is of general payments naming this product to practitioners with a specialty in 2020. Each practitioner is counted under their primary specialty.

Where the money went General payments · program year 2020
  1. Oklahoma $20 33% · 1 recipient
  2. Louisiana $16 27% · 1 recipient
  3. Maine $14 23% · 1 recipient
  4. Massachusetts $4 6% · 1 recipient
  5. Alabama $2 3% · 1 recipient

The top 5 of 8 states; each share is of general payments naming this product in 2020 where a state was reported.

The top 25 states, free in the app

13 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2020

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record